Parkinson's disease is a tough condition. It slowly destroys brain cells that produce dopamine, a chemical that helps control movement. Right now, there's no cure. Treatments only help with symptoms and can cause problems over time. Enter Lingjiao Gouteng decoction, a traditional Chinese medicine.
Bayern Munich faced a tough challenge in the Champions League, losing 3-1 to Arsenal. The team struggled to create many scoring chances throughout the game. Serge Gnabry, who played almost the entire match, shared his thoughts on the performance. He acknowledged that Arsenal was the better team. Th
Bay City is known for its lively spirit, and this weekend was no exception. Instead of the usual downtown festivities, the town engaged in two unique events that combined fun with a sense of community. The first event was the Bay City Noon Optimist Club's annual fundraiser, held at the Kawkawlin To
Parkinson's disease is a tough challenge. It affects the body and the mind. Modern medicine has made big strides. It can fix hearts, change genes, and even lengthen lives. But there's something missing. The human spirit is often left out of the equation. Living with Parkinson's has shown that heali
Parkinson's disease is a tough condition to manage. Over the years, deep brain stimulation (DBS) has become a common treatment. But, there wasn't a clear plan for how to take care of patients after the surgery. This is where a group of experts stepped in. They decided to create a standard way to ma
Bayesian statistics is a powerful tool for making sense of data. It helps us understand the uncertainty around our estimates. But what happens when our models are not perfect? This is called model misspecification. In such cases, Bayesian posteriors may not accurately reflect the true uncertainty. M
Bayer AG, a big name in pharmaceuticals and life sciences, is teaming up with Celonis SE. They're using process intelligence and AI to make things run smoother. This isn't just about new tech. It's about changing how people work and think. Timo Peters, who leads process insights at Bayer, talked ab
Parkinson's disease is becoming more common. In the last 25 years, the number of people with this condition has doubled. Experts predict it will double again soon. Yet, the main treatment for Parkinson's, a drug called levodopa, is hard to find in many places. This drug is cheap, effective, and can
Parkinson's disease might be more than just a movement disorder. Recent findings hint that it could also mess with how the body handles sugar. This isn't just about diabetes, but also about low blood sugar, or hypoglycemia. A study took a closer look at this, tracking blood sugar levels in Parkinson
Parkinson's disease is a growing concern globally, affecting millions with its mix of movement and non-movement related symptoms. While dopamine-based treatments like levodopa are common, they often fall short for non-movement issues and can cause unwanted side effects. Researchers are looking into
